找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Drug Discovery from Mother Nature; Subash Chandra Gupta,Sahdeo Prasad,Bharat B. Aggar Book 2016 The Editor(s) (if applicable) and The Auth

[復(fù)制鏈接]
樓主: detumescence
51#
發(fā)表于 2025-3-30 08:36:40 | 只看該作者
52#
發(fā)表于 2025-3-30 16:13:25 | 只看該作者
53#
發(fā)表于 2025-3-30 17:29:02 | 只看該作者
54#
發(fā)表于 2025-3-30 23:55:25 | 只看該作者
55#
發(fā)表于 2025-3-31 03:22:08 | 只看該作者
Novel Strategies to Control , and Dengueoseraceae, and Ebenaceae. Plumbagin has exhibited its potential therapeutic benefits on numerous chronic diseases, i.e., breast cancer, non-small cell lung cancer, melanoma, ovarian, squamous cell carcinomas, pancreatic cancer, and prostate cancer. In addition, its anti-inflammatory and antimicrobia
56#
發(fā)表于 2025-3-31 06:17:41 | 只看該作者
57#
發(fā)表于 2025-3-31 12:47:24 | 只看該作者
A Commonsense View and Its Problemstment of inflammation, cancer, and other chronic diseases and is known for good efficiency and very low side effects. Primary studies on the mechanism of action revealed that indirubin and derivatives are potent ATP-competitive inhibitors of CDKs and GSK3? achieving IC. values down to the low nanomo
58#
發(fā)表于 2025-3-31 15:44:58 | 只看該作者
https://doi.org/10.1007/978-90-481-8816-1s to create novel derivatives with higher desired activities. Oleanolic acid, a component of traditional Chinese medicine used in hepatitis therapy, was modified by chemical processes to form 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid (CDDO). This modification increased anti-inflammatory activity
59#
發(fā)表于 2025-3-31 18:41:12 | 只看該作者
60#
發(fā)表于 2025-3-31 23:14:27 | 只看該作者
Diversity and Teacher Educationrious disorders, including internal tumors, obesity, liver disorders, malignant sores and ulcers, urinary complaints, intestinal worms, leucoderma, sinuses, edema, and sudden paralytic seizures. Guggulsterone has been identified a bioactive components of this gum resin. This plant steroid has been r
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-13 05:25
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
綦江县| 宜黄县| 怀来县| 桂林市| 白朗县| 丹江口市| 日照市| 新营市| 塔城市| 遂宁市| 巴林右旗| 富川| 鱼台县| 奉新县| 手机| 佳木斯市| 江川县| 崇礼县| 嘉兴市| 易门县| 称多县| 邢台县| 新沂市| 枣阳市| 阿瓦提县| 阿城市| 且末县| 九台市| 大丰市| 新安县| 泸溪县| 潮安县| 双桥区| 蒲江县| 林周县| 贺兰县| 平凉市| 陇西县| 凤翔县| 天峻县| 永靖县|